Evidence map›Paper›PMID 40048461›Full record

ArticlePloS one2025

Prediction of drug target interaction based on under sampling strategy and random forest algorithm.

Feng Chen, Zhigang Zhao, Zheng Ren, Kun Lu, Yang Yu, Wenyan Wang

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Feng ChenSchool of Advanced Manufacturing Engineering, Hefei University, Hefei, China.
Zhigang ZhaoSchool of Electrical and Information Engineering, Anhui University of Technology, Ma'anshan, Anhui, China.
Zheng RenSchool of Electrical and Information Engineering, Anhui University of Technology, Ma'anshan, Anhui, China.
Kun LuSchool of Electrical and Information Engineering, Anhui University of Technology, Ma'anshan, Anhui, China.
Yang YuSchool of Advanced Manufacturing Engineering, Hefei University, Hefei, China.
Wenyan WangSchool of Electrical and Information Engineering, Anhui University of Technology, Ma'anshan, Anhui, China.ORCID https://orcid.org/0009-0008-9786-0272

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug target interactions (DTIs) play a crucial role in drug discovery and development. The prediction of DTIs based on computational method can effectively assist the experimental techniques for DTIs identification, which are time-consuming and expensive. However, the current computational models suffer from low accuracy and high false positive rate in the prediction of DTIs, especially for datasets with extremely unbalanced sample categories. To accurately identify the interaction between drugs and target proteins, a variety of descriptors that fully show the characteristic information of drugs and targets are extracted and applied to the integrated method random forest (RF) in this work. Here, the random projection method is adopted to reduce the feature dimension such that simplify the model calculation. In addition, to balance the number of samples in different categories, a down sampling method NearMiss (NM) which can control the number of samples is used. Based on the gold standard datasets (nuclear receptors, ion channel, GPCRs and enzymes), the proposed method achieves the auROC of 92.26%, 98.21%, 97.65%, 99.33%, respectively. The experimental results show that the proposed method yields significantly higher performance than that of state-of-the-art methods in predicting drug target interaction.

Indexed as

AlgorithmsDrug DiscoveryComputational BiologyHumansRandom Forest

Identifiers

PMID40048461
PMCPMC11884685

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.